Comparing two antibiotics for mycoplasma pneumonia in children
Treatments studied
Part of Infections, Lungs & breathing clinical trials.
This study compares two antibiotics, doxycycline and a macrolide, to see which works better for children with pneumonia caused by a bacteria called Mycoplasma pneumoniae, especially when the bacteria might be resistant to the usual treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 3 and 17 years old.
- You have pneumonia confirmed by a chest X-ray and symptoms like fever, cough, or abnormal lung sounds.
- You have or are strongly suspected to have a bacterial infection called Mycoplasma pneumoniae.
- Your infection is thought to be resistant to common antibiotics (macrolides).
- You must start the study medicine within 72 hours of your symptoms beginning.
- You have not already taken tetracycline, macrolide, or quinolone antibiotics for this illness.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether azithromycin (a macrolide antibiotic) is better than a placebo for treating mycoplasma pneumonia in children aged 3–17. If your child has pneumonia caused by mycoplasma, this study may help find the best treatment.
This trial compares azithromycin and doxycycline for adults hospitalized with community-acquired pneumonia who are already getting a beta-lactam antibiotic. It aims to see which works better as an add-on treatment.
This trial compares different antibiotic strategies for children with pneumonia who are being treated as outpatients. The goal is to find the best approach to treat the infection and help your child recover.
This trial tests a new antibiotic (omadacycline) compared to a standard one (moxifloxacin) for adults with community-acquired pneumonia. The goal is to see if the new drug is as safe and effective.
This trial tests whether the antibiotic azithromycin can help children in the hospital who are having asthma-like breathing symptoms. If you qualify, your child may get azithromycin as part of the study and will be monitored closely for side effects and breathing improvement.
This Phase 3 trial compares two antibiotics—clarithromycin and azithromycin—to treat lung infection caused by Mycobacterium avium complex (MAC). It may help by showing which antibiotic works better and is safer for people who need MAC treatment.
Hear when a new Mycoplasma Pneumoniae trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.